12/07/2024 - Press release
The new method would allow for a more objective and precise classification of patients' types of osteoarthritis, supported by data mining techniques and biological modeling, which enable the analysis and processing of large volumes of information. Pompeu Fabra University (UPF) and Hospital del Mar have designed a new method to classify the types of knee osteoarthritis that patients suffer from in a more objective and precise way.
27/06/2024 - Press release
Gastric bypass is more effective than the other common approach, vertical sleeve gastrectomy, in reducing LDL cholesterol levels. This is a common comorbidity in patients undergoing this type of surgery and a primary agent causing atherosclerosis. This is revealed in a study by the Bariatric Surgery Unit at Hospital del Mar, published in the journal Cardiovascular Diabetology. The study's authors argue that this fact should be considered when deciding which technique to use for each patient.
05/06/2024 - Press release
A scientific team led by Dr Anna Bigas, from the Hospital del Mar Research Institute and the Josep Carreras Institute, has described the role of the IκBα protein in the differentiation process of haematopoietic cells. In the absence of this protein, the stem cells enter quiescence, acquire a dormant state and maintain their potential, which may allow them to be transplanted for therapeutic uses in leukaemia or blood diseases of genetic origin. This is an important step towards being able to generate these types of cells in the lab, preventing them from differentiating and turning into other cells too early.
29/05/2024 - Press release
An international study led by the Hospital del Mar Medical Research Institute has demonstrated, for the first time, the role of two proteins in the activation and deactivation of the system through which drugs act against schizophrenia symptoms. These two proteins are potential targets for developing new drugs aimed at specific symptoms of the disease, avoiding the side effects of current treatments. The study analyzed how certain molecules act on a serotonin cell receptor, which could allow for differentiated effects on schizophrenia symptoms without affecting other brain processes.
Més informació "New Avenues to Developing Personalized Treatments for Schizophrenia"
21/05/2024 - Press release
A systematic review and meta-analysis of the scientific evidence published between 2000 and 2021 estimates the recurrence risk in people who have suffered a minor stroke, a stroke that does not cause sequelae. The study is published by the Journal of the American Heart Association and includes participation from the Neurology Service of Hospital del Mar. Almost one in ten people who suffer a stroke without sequelae, known as a minor stroke, will experience a second stroke within three months of the first episode. This is established by a recent study led by researchers from the University of Melbourne in Australia, with participation from the Neurology Service of Hospital del Mar. The work, a systematic review and meta-analysis of 14 publications on the subject, is published by the Journal of the American Heart Association. It is the largest study on this type of pathology conducted to date.
14/05/2024 - Press release
Individuals hospitalized for acute exacerbations of chronic obstructive pulmonary disease (COPD) exhibit elevated blood levels of proteins that promote blood clotting, according to a study from Hospital del Mar published in ERJ Open Research. This increases their risk of cardiovascular complications. For this reason, the authors of the study recommend that these patients always receive systematic and preventative anticoagulant treatment during their hospital stay. The same study also points out the need for rigorous monitoring of people with COPD who experience three or more exacerbations per year, as their blood protein profile when stable is very similar to that of individuals hospitalized for this condition.
06/05/2024 - Press release
Dr. Torrens is a Professor of Psychiatry, while Dr. Pujol is a Professor of Dermatology. Both at the Department of Medicine and Health Sciences of UPF. Dr. Marta Torrens, emeritus director of Addiction at Hospital del Mar, has been appointed Professor of Psychiatry at the Department of Medicine and Health Sciences of Pompeu Fabra University since April 16, after successfully passing the opposition process. Dr. Torrens also serves as the coordinator of the Addiction Research Group at the center's Research Institute. Dr. Ramon M. Pujol, head of the Dermatology Service at the hospital and coordinator of the Research Group on Inflammatory and Neoplastic Dermatologic Diseases at the Hospital del Mar Research Institute, won the competition for the position of Professor of Dermatology at UPF on April 17.
03/05/2024 - Press release
Natural Killer (NK) cells, when exposed to antibody treatment used against HER2-positive breast cancer, secrete specific types of cytokines that activate the immune response against tumor cells. Researchers have confirmed that patients with NK lymphocytes present in the tumor environment show a better response to treatment, thanks to this mechanism. This confirms the feasibility of using cytokines secreted by NK cells as markers of response to anti-HER2 antibodies with a simple blood test. It also reaffirms various clinical trials using these lymphocytes to bolster treatment in patients with metastatic HER2-positive breast cancer.
11/04/2024 - Press release
It has received a grant from the Carlos III Health Institute to be part of the ISCIII platform for the dynamization and innovation of the industrial capacities of the National Health Service. The project of the Innovation and Digital Transformation Unit presented by the Hospital del Mar research institute on the ITEMAS platform for the dynamization and innovation of the industrial capacities of the National Health Service of the Carlos III Health Institute (ITEMAS ISCIII) will receive a grant of about 300.000 euros for its development in the period 2024-2026. The initiative, coordinated by the Parc Taulí Research and Innovation Institute (I3PT), will have 26 innovation support units and more than a hundred collaborators throughout the State.
09/04/2024 - Press release
A two-year project funded by the EU Horizon 2020 program Protecting mental health in times of change. Santa Coloma de Gramenet will host a large-scale European project, MENTBEST, starting from September 2024, led by Dr. Benedikt Amann from Hospital del Mar Barcelona. The project aims to address suicide prevention and the reduction of depression and emotional distress in communities undergoing rapid transformation in a community-based approach.
Més informació "The MENTBEST Project kicks off in Santa Coloma de Gramenet."
Servei de Comunicació:
Marta Calsina Freixas(ELIMINAR)
Tel:
(+34) 93 316 06 80
Doctor Aiguader, 88
08226 Barcelona
© Institut Hospital del Mar
d'Investigacions MèdiquesLegal Notice and Privacy Policy | Cookie Policy | Site Index | Accessibility | Find Us | Contact
